今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1481次   下载 1334 本文二维码信息
码上扫一扫!
分享到: 微信 更多
银翘散调节呼吸道病毒感染相关性哮喘Th1/Th2细胞因子的临床观察
常力, 朱振刚
天津中医药大学第一附属医院呼吸科, 天津 300193
摘要:
[目的] 观察银翘散对呼吸道病毒感染相关性哮喘(RVA)的临床疗效及对Th1/Th2细胞因子的影响。[方法] 将68例RVA患者随机分为对照组32例,常规西药治疗;治疗组36例,在常规西药的基础上加用银翘散治疗。2组均治疗10 d。观察治疗前后患者的哮喘控制评分(ACT),肺功能[第1秒时间肺活量(FEV1)、一秒率(FEV1/FVC%)、呼气峰流速(PEF)]、中医证候疗效及Th1/Th2细胞因子[分泌性免疫球蛋白A(sIgA)、白介素-4(IL-4)、γ干扰素(IFN-γ)、IFN-γ/IL-4]的变化。[结果] 治疗后两组患者的ACT评分均较治疗前明显改善,且治疗组优于对照组(P<0.05);治疗组对肺功能的改善优于对照组(P<0.05)。治疗组中医证候有效率为94.44%(34/36),对照组中医证候有效率为71.87%(23/32)。治疗后,治疗组sIgA水平高于对照组(P<0.05)。IFN-γ及IFN-γ/IL-4低于对照组(P<0.05),IL-4水平两组之间未见差异(P>0.05)。[结论] 银翘散联合常规西药治疗RVA的临床疗效优于单用常规西药治疗,可能与银翘散可调节患者Th1/Th2细胞因子,逆转因子间的失衡,进而减少气道炎症相关。
关键词:  呼吸道病毒感染相关性哮喘  银翘散  Th1/Th2  IFN-γ/IL-4
DOI:10.11656/j.issn.1672-1519.2018.04.08
分类号:R562.2
基金项目:
Clinical observation of Yinqiao powder for regulating respiratory virus associated asthma in Th1/Th2 cytokines
CHANG Li, ZHU Zhengang
Pneumology Department, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
Abstract:
[Objective] To observe the clincal effect of Yinqiao powder on treating the respiratory virus associated Asthma(RVA) and Th1/Th2 cytokines. [Methods] The 68 RVA patients were randomly divided into control group (32 cases, conventional Western medicine treatment) and treatment group (36 cases, conventional Western medicine treatment+Yinqiao powder). Two groups were treated 10 days. In prior-treatment and post-treatment, the change of the related indexes were observed, including the asthma control test (ACT score), lung function(FEV1, FEV1/FVC%, PEF), curative effect of TCM and Th1/Th2 cytokines (sIgA, IL-4, IFN-γ, IFN-γ/IL-4). [Results] After treatment, two groups of ACT score was obviously improved, the treatment group was better than that of control group (P<0.05). On the lung function improvement, the treatment group was better than the control group(P<0.05). On TCM symptoms, the treatment group effective rate was 94.44% (34/36), the control of the effective rate was 71.87% (23/32). After treatment, the treatment group sIgA levels higher than the control group (P<0.05). IFN-4 and IFN-γ/IL-4 is lower than the control group (P<0.05), IL-4 levels not seen differences between two groups (P>0.05). [Conclusion] Yinqiao Powder combined with conventional Western medicine therapy RVA clinical curative effect is superior to the conventional Western medicine therapy, this may be related to Yinqiao Powder can regulate Th1/Th2 cytokines of patients, reverse the imbalance between factors, thereby reducing the airway inflammation.
Key words:  respiratory virus associated asthma  Yinqiao powder  Th1/Th2  IFN-γ/IL-4
关注公众号二维码